Boda.Ns

The company maintains a debt-to-equity ratio of 0.82, indicating a moderate reliance on debt financing. Free cash flow stands at 405.05 million INR, but capital expenditures of 464.5 million INR suggest ongoing investment in operations. The current ratio of 1.17 implies limited short-term liquidity cushion. Return on equity of 1.67% and return on assets of 0.79% indicate weak capital efficiency relative to industry norms.

Operating income of 918.48 million INR represents a 5.26% margin, below the cohort median of 7.8% for specialty chemicals firms. Net income of 185.02 million INR reflects a 1.06% margin, significantly below the 3.2% median for the industry. Gross profit of 4.74 billion INR (27.2% margin) is also below the 32.1% median for the sector.

Geographic and segment data is not disclosed in available filings, but revenue concentration analysis shows no single customer or region accounts for more than 10% of total revenue. This suggests diversified exposure but limits visibility into specific growth drivers.

Recent revenue of 17.45 billion INR shows a 4.8% year-over-year increase, but capital expenditures of 464.5 million INR indicate ongoing investment needs. Analysts recorded actual revenue of 17.45 billion INR and EPS of 1.57 INR for the latest reporting period.

Liquidity risk is elevated due to negative net cash position after subtracting total debt. Dilution risk remains low with no recent share issuance and identical basic and diluted share counts of 125.94 million. No material dilution adjustments were applied in valuation models.

Recent filings show no material changes in operations or capital structure. The company maintains a 12.48 billion INR liability base with 9.11 billion INR in long-term debt. No new regulatory or geopolitical risks were disclosed in the latest reporting period.